Use of sugammadex in patients with a history of pulmonary disease

Journal of Clinical Anesthesia

Volumn 24, Issue 4, 2012, Pages 289-297

  Amao, Rasheed ^a   Zornow, Mark H ^b   Cowan, Robert McTaggart ^c   Cheng, Davy C ^d   Morte, Jovino B ^e   Allard, Martin W ^f  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c FOOTHILLS HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e MERCK RESEARCH LABORATORIES   (United States)

^f LOMA LINDA UNIVERSITY   (United States)

Author keywords

Bronchospasm; Chronic obstructive pulmonary disease; Neuromuscular blockade; Pulmonary disease; Rocuronium; Sugammadex

Indexed keywords

BECLOMETASONE; DESFLURANE; DEXAMETHASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; ROCURONIUM; SALBUTAMOL; SUGAMMADEX; TERBUTALINE;

ADULT; ALBUMIN BLOOD LEVEL; ANESTHESIA INDUCTION; ASTHMA; BLEEDING; BODY TEMPERATURE; BRONCHOSPASM; CALCIUM BLOOD LEVEL; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY OBSTRUCTION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE; FEMALE; FLATULENCE; GENERAL ANESTHESIA; GEOMETRY; HEADACHE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LABORATORY TEST; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; PAIN; PARALLEL DESIGN; PERIPHERAL ISCHEMIA; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE NAUSEA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RHINOSINUSITIS; SEROMA; SIDE EFFECT; TOBACCO DEPENDENCE; VITAL SIGN; VOMITING;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE CARE;

EID: 84861164573     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2011.09.006     Document Type: Conference Paper

References (36)

1. R.L. Sakai, G.M. Abrão, J.F. Ayres, P.T. Vianna, L.R. Carvalho, and Y.M. Castiglia Prognostic factors for perioperative pulmonary events among patients undergoing upper abdominal surgery Sao Paulo Med J 125 2007 315 321
2. D.H. Bremerich Anesthesia in bronchial asthma Anasthesiol Intensivmed Notfallmed Schmerzther 35 2000 545 558
3. H. Groeben Strategies in the patient with compromised respiratory function Best Pract Res Clin Anaesthesiol 18 2004 579 594
4. M. Mercer Anaesthesia for the patient with respiratory disease Update in Anaesthesia 12 2000 51 58 Available at http://update.anaesthesiologists.org/wp- content/uploads/file/Update%2012%20(2000).pdf
5. D.H. Wong, E.C. Weber, M.J. Schell, A.B. Wong, C.T. Anderson, and S.J. Barker Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease Anesth Analg 80 1995 276 284
6. G.W. Smetana Preoperative pulmonary evaluation N Engl J Med 340 1999 937 944
7. A. Chetta, P. Tzani, E. Marangio, P. Carbognani, A. Bobbio, and D. Olivieri Respiratory effects of surgery and pulmonary function testing in the preoperative evaluation Acta Biomed 77 2006 69 74
8. H. Berg, J. Roed, and J. Viby-Mogensen Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium Acta Anaesthesiol Scand 41 1997 1095 1103
9. B. Debaene, B. Plaud, M.P. Dilly, and F. Donati Residual paralysis in the PACU after a single intubating dose of depolarizing muscle relaxant with an intermediate duration of action Anesthesiology 98 2003 1042 1048
10. K.S. Kim, S.H. Lew, H.Y. Cho, and M.A. Cheong Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine Anesth Analg 95 2002 1656 1660
11. E.M. Gruber, and E.M. Tschernko Anaesthesia and postoperative analgesia in older patients with chronic obstructive pulmonary disease: special considerations Drugs Aging 20 2003 347 360
12. U. Bissinger, F. Schimek, and G. Lenz Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium Physiol Res 49 2000 455 462
13. J.M. Van Vlymen, and J.L. Parlow The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period Anesth Analg 84 1997 148 154
14. L.H. Booij, H.D. De Boer, and J. Van Egmond Reversal agents for nondepolarizing neuromuscular blockade: reasons for and development of a new concept Semin Anesth Periop Med Pain 21 2002 92 98
15. http://emc.medicines.org.uk/medicine/20888/SPC/ Neostigmine+Methylsulphate+ Injection+BP+2.5mg+in+1ml/#CLINICAL-PRECAUTIONS, Accessed December 15, 2009.
16. M. Feinberg The problems of anticholinergic adverse effects in older patients Drugs Aging 3 1993 335 348
17. A. Hazizaj, and A. Hatija Bronchospasm caused by neostigmine Eur J Anaesthesiol 23 2006 85 86
18. A. Bom, M. Bradley, and K. Cameron A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host Angew Chem Int Ed Engl 41 2002 266 270
19. M. Shields, M. Giovannelli, R.K. Mirakhur, I. Moppett, J. Adams, and Y. Hermens Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block Br J Anaesth 96 2006 36 43
20. I.F. Sorgenfrei, K. Norrild, and P.B. Larsen Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex Anesthesiology 104 2006 667 674
21. K. Suy, K. Morias, and G. Cammu Sugammadex, a selective relaxant binding agent, offers effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block Anesthesiology 106 2007 283 288
22. S.B. Groudine, R. Soto, C. Lien, D. Drover, and K. Roberts A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block Anesth Analg 104 2007 555 562
23. H. Sparr, K.M. Vermeyen, and A.M. Beaufort Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety and pharmacokinetics Anesthesiology 106 2007 935 943
24. B.F. Vanacker, K.M. Vermeyen, and M.M. Struys Reversal of rocuronium-induced neuromuscular block with the novel agent sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane Anesth Analg 104 2007 563 568
25. R.K. Jones, J.E. Caldwell, S.J. Brull, and R.G. Soto Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine Anesthesiology 109 2008 816 824
26. J. Viby-Mogensen, J. Engbaek, and L.I. Eriksson Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents Acta Anaesthesiol Scand 40 1996 59 74
27. O. Sacan, P.F. White, B. Tufanogullari, and K. Klein Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine Anesth Analg 104 2007 569 574
28. Y. Dikmen, E. Eminoglu, Z. Salihoglu, and S. Demiroluk Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia Anaesthesia 58 2003 745 748
29. M.J. Goff, S.R. Arain, D.J. Ficke, T.D. Uhrich, and T.J. Ebert Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental Anesthesiology 93 2000 404 408
30. G. Liccardi, A. Salzillo, F. De Blasio, and G. D'Amato Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anesthesia and/or intravascular administration of radiographic contrast media Curr Med Res Opin 25 2009 1621 1630
31. Available at: http://www.medicines.org.uk/EMC/medicine/21299/SPC/ Bridion+100+mg+ml+solution+for+injection/.
32. G.L. Olsson Bronchospasm during anaesthesia. A computer-aided incidence study of 136,929 patients Acta Anaesthesiol Scand 31 1987 244 252
33. D.O. Warner, M.A. Warner, and R.D. Barnes Perioperative respiratory complications in patients with asthma Anesthesiology 85 1996 460 467
34. S.M. Shnider, and E.M. Papper Anesthesia for the asthmatic patient Anesthesiology 22 1961 886 892
35. Y. Kumeta, A. Hattori, M. Mimura, K. Kishikawa, and A. Namiki A survey of perioperative bronchospasm in 105 patients with reactive airway disease Masui 44 1995 396 401
36. Available at: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008- 4346b1-02-Organon.pdf. Accessed February 20, 2011.